Feasibility and Outcome of Reduced‐Intensity Conditioning in Haploidentical Transplantation
- 1 June 2007
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1106 (1) , 279-289
- https://doi.org/10.1196/annals.1392.022
Abstract
Allogeneic stem cell transplantation is for a number of patients with malignant and nonmalignant diseases the only curative approach. For those patients who do not have an HLA-identical-related or -unrelated stem cell donor, a related three-loci mismatch haploidentical stem cell transplantation with T cell-depleted stem cells is a viable option. T cell depletion either by CD34(+) positive selection or by CD3-negative depletion strategies is available and has been investigated. We have shown that reduced-intensity conditioning haploidentical transplantation using mobilized peripheral stem cells negatively depleted from T and B lymphocytes is associated with a rapid immune reconstitution, a low transplant-related mortality rate, and a favorable outcome in patients in remission at the time of transplant. For chemorefractory patients, additional posttransplant cellular and humoral immunotherapeutic strategies are needed for prevention of relapse after transplantation.Keywords
This publication has 35 references indexed in Scilit:
- Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantationBritish Journal of Haematology, 2006
- Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant PatientsTransplantation, 2006
- A Comparison between Three Graft Manipulation Methods for Haploidentical Stem Cell Transplantation in Pediatric Patients: Preliminary Results of a Pilot StudyKlinische Padiatrie, 2005
- Cytotoxic minor histocompatibility antigen HA-1–specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro inductionBlood, 2005
- Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantationBone Marrow Transplantation, 2005
- Use of natural killer cells in hematopoetic stem cell transplantationBone Marrow Transplantation, 2005
- Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patientsBone Marrow Transplantation, 2004
- Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood, 2002
- A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cellsBone Marrow Transplantation, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002